Inovytec Medical Solutions

Company Overview

Snapshot

Founded in February 2011 by Udi Kantor, Hillel Lapidot, and Michael Lantsman, Inovytec Medical Solutions operates with 11–50 employees. The company has raised $8.6 million across 4 funding rounds from 5 investors. In September 2021, Inovytec decided to abandon its plans for an IPO in Tel Aviv, instead aiming for a Nasdaq IPO in 2022 with a target valuation of $150 million.

Business overview

Inovytec Medical Solutions develops innovative products designed to enhance survivability in out-of-hospital medical emergencies. Its core products include SALI, an automated oxy-defibrillator with real-time telemonitoring; LUBO, an upper-airway opening device for noninvasive airway management; and VENTWAY, an ultralight ventilator for critical care and oxygen therapy in field conditions. The company serves the medical devices and digital healthcare sectors, focusing on patient remote monitoring, and targets healthcare providers, patients, and military organizations.

Strategic signal

In December 2021, Inovytec Medical Solutions was recognized as Israel's fastest-growing company by Globes and Statista, achieving a 460.1% growth rate between 2017 and 2020. This ranking highlights the company's strong market traction and operational efficiency, particularly in the mobile respirator market, signaling robust growth potential to investors and innovation teams.

Company Intelligence Q&A

What was Inovytec Medical Solutions' strategy regarding its public offering in September 2021?

In September 2021, Inovytec Medical Solutions decided to forgo its planned IPO on the Tel Aviv Stock Exchange, where it had sought a valuation of 318 million shekels. Instead, the company shifted its focus to a Nasdaq IPO in 2022, targeting a higher valuation of $150 million.

What significant recognition did Inovytec Medical Solutions receive in December 2021?

In December 2021, Inovytec Medical Solutions was ranked as the fastest-growing company in Israel by Globes and Statista, based on an average revenue growth rate of 460.1% between 2017 and 2020.

What strategic partnership did Inovytec Medical Solutions form in June 2021?

In June 2021, Inovytec Medical Solutions signed a strategic distribution agreement with Healthsoft to supply its Ventway Sparrow portable advanced ventilators to the UAE. This agreement followed the ventilators' approval by the UAE Ministry of Health and Prevention.

What regulatory milestone did Inovytec Medical Solutions achieve in February 2021?

In February 2021, Inovytec Medical Solutions received FDA 510(k) clearance to market and sell its Ventway Sparrow line of ventilators in the United States, expanding its market reach beyond Europe, Canada, and Australia.

What was the nature of Inovytec Medical Solutions' partnership with ADS Inc. in March 2021?

In March 2021, Inovytec Medical Solutions signed a strategic distribution agreement with Atlantic Diving Supply Inc. (ADS) to position Inovytec as a long-term medical supplier for the defense industry, specifically for its Ventway Sparrow Robust tactical ventilators.